Norme di riordino del settore farmaceutico

This procedure concerns the reorganisation of the pharmaceutical sector in Italy. It aims to update and streamline regulations governing the production, distribution, and sale of medicines. The changes will affect pharmaceutical companies, healthcare providers, and ultimately patients, potentially impacting drug availability and pricing.